CIPLA's weekly performance was disappointing, with a return of -1.57%, underperforming its peers SUNPHARMA and DIVISLAB. The stock's volatility was moderate at 10.78%, but its Sharpe Ratio of -0.58 indicates that the return was not sufficient to compensate for the risk taken. CIPLA was the riskiest among its peers this week, with a Max Drawdown of -1.68%. Overall, CIPLA's weekly performance was lackluster and failed to impress.

[Volatility: 10.78%]